Redcliffe Labs Partners with RGCB to Boost Genomics Research in India

This partnership aims to introduce advanced genomics technologies to the southern part of India, making these resources more accessible and efficient.

Redcliffe Labs, a Noida-based startup, has joined forces with the Rajiv Gandhi Centre for Biotechnology (RGCB) in Thiruvananthapuram to manage and operate a laboratory equipped with Single Cell Genomics and High-Throughput Sequencing technologies.

This partnership aims to introduce advanced genomics technologies to the southern part of India, making these resources more accessible and efficient. Technologies such as 10X Chromium, Illumina Novaseq, Nanopore Gridion, and other associated infrastructures will be incorporated, streamlining the processing and analysis of genetic samples.

By establishing a lab in Thiruvananthapuram, Redcliffe Labs became the first company in India to boast two fully equipped genomics facilities.

Expressing the objective of this partnership, Ashish Dubey, director of research at Redcliffe Labs, said, "We aim to provide efficient, cost-effective, and high throughput Next-Generation Sequencing (NGS) services to various research centers in Kerala. This facility will support numerous genomics startups in Kerala, emerging as a new hub for such ventures."

The collaboration between Redcliffe Labs and RGCB promises to advance genomics research in India.

Commenting on the same, Prof Chandrabhas Narayana, director at RGCB, Thiruvananthapuram, highlighted the significance of genomics-based technologies, stating, "NGS technologies assist researchers and breeders in evaluating and predicting genetic characteristics."

Redcliffe Labs, founded in 2018 in Noida, is expanding its diagnostic network. The company processes over 250,000 test parameters daily and offers over 3600 tests across 80+ labs and 2000+ collection centers.

In a previous development in September, Redcliffe Labs introduced precise metrics to improve the accuracy of identifying Polycystic Ovary Syndrome (PCOS).

These metrics provide healthcare professionals with a highly accurate tool for diagnosing PCOS efficiently, promising to streamline the diagnostic process and facilitate timely interventions and treatments.

This collaboration between Redcliffe Labs and RGCB holds great promise for the future of genomics research in India, with the potential to drive innovations that will benefit various sectors, including healthcare and agriculture.